CoChat

Epigenetic Alterations Affecting Transcription Factors and Signaling Pathways in Stromal Cells of Endometriosis

Open access

The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.

Abstract

Endometriosis is characterized by growth of endometrial-like tissue outside the uterine cavity. Since its pathogenesis may involve epigenetic changes, we used Illumina 450K Methylation Beadchips to profile CpG methylation in endometriosis stromal cells compared to stromal cells from normal endometrium. We validated and extended the Beadchip data using bisulfite sequencing (bis-seq), and analyzed differential methylation (DM) at the CpG-level and by an element-level classification for groups of CpGs in chromatin domains. Genes found to have DM included examples encoding transporters (SLC22A23), signaling components (BDNF, DAPK1, ROR1, and WNT5A) and transcription factors (GATA family, HAND2, HOXA cluster, NR5A1, OSR2, TBX3). Intriguingly, among the TF genes with DM we also found JAZF1, a proto-oncogene affected by chromosomal translocations in endometrial stromal tumors. Using RNA-Seq we identified a subset of the DM genes showing differential expression (DE), with the likelihood of DE increasing with the extent of the DM and its location in enhancer elements. Supporting functional relevance, treatment of stromal cells with the hypomethylating drug 5aza-dC led to activation of DAPK1 and SLC22A23 and repression of HAND2, JAZF1, OSR2, and ROR1 mRNA expression. We found that global 5hmC is decreased in endometriotic versus normal epithelial but not stroma cells, and for JAZF1 and BDNF examined by oxidative bis-seq, found that when 5hmC is detected, patterns of 5hmC paralleled those of 5mC. Together with prior studies, these results define a consistent epigenetic signature in endometriosis stromal cells and nominate specific transcriptional and signaling pathways as therapeutic targets.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0170859

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Gene-specific alterations in DNA methylation in primary ovarian endometriosis stromal cells (OESC) compared to control endometrial stromal cells (CESC), chromatin state enrichment analysis of DM genes in endometriosis, and bi-seq validation for DAPK1. A) Heat maps of gene-specific methylation changes in endometriotic stroma cells vs. controls. Supervised hierarchical clustering of the 450K methylation BeadChip data analyzed at the CpG level (FDR q-values < .05 and absolute difference in fractional methylation (Δmethyl.)>.15) and at the element-level (q-values < .05 and Δmethyl.>.15 for multiple CpG segment and>0.1 for single CpG segment) are shown. Biological samples are on the x-axis and differentially methylated loci are on the y-axis, with relative hypermethylation and hypomethylation indicated by the color scale. The fractional methylation values for each CpG are centered and standardized to have mean 0 and standard deviation 1. The red color represents a methylation level above the mean methylation of the CpG across all samples, the white color represents mean methylation and the blue color represents methylation lower than the mean. B) DM CpGs are enriched in enhancers but depleted in promoter regions. For each chromatin state, enrichment and under-representation are symmetrically visualized using log2(OR). C) Validation and mapping of the DMR in DAPK1 using bis-seq. A map of the DAPK1 gene showing hypomethylation in the promoter region is given on the top. The DMR overlaps an active promoter region (color coded in red) flanked by a strong enhancer (yellow). Bis-seq amplicons for validation and mapping of the DMR are indicated by the numbered rectangles. The bis-seq data (bottom panel) is visualized by the circles representing consecutive CpGs with black circles indicating methylated CpGs and white circles unmethylated CpGs, with each line being a unique DNA clone.
Fig 1 Gene-specific alterations in DNA methylation in primary ovarian endometriosis stromal cells (OESC) compared to control endometrial stromal cells (CESC), chromatin state enrichment analysis of DM genes in endometriosis, and bi-seq validation for DAPK1. A) Heat maps of gene-specific methylation changes in endometriotic stroma cells vs. controls. Supervised hierarchical clustering of the 450K methylation BeadChip data analyzed at the CpG level (FDR q-values < .05 and absolute difference in fractional methylation (Δmethyl.)>.15) and at the element-level (q-values < .05 and Δmethyl.>.15 for multiple CpG segment and>0.1 for single CpG segment) are shown. Biological samples are on the x-axis and differentially methylated loci are on the y-axis, with relative hypermethylation and hypomethylation indicated by the color scale. The fractional methylation values for each CpG are centered and standardized to have mean 0 and standard deviation 1. The red color represents a methylation level above the mean methylation of the CpG across all samples, the white color represents mean methylation and the blue color represents methylation lower than the mean. B) DM CpGs are enriched in enhancers but depleted in promoter regions. For each chromatin state, enrichment and under-representation are symmetrically visualized using log2(OR). C) Validation and mapping of the DMR in DAPK1 using bis-seq. A map of the DAPK1 gene showing hypomethylation in the promoter region is given on the top. The DMR overlaps an active promoter region (color coded in red) flanked by a strong enhancer (yellow). Bis-seq amplicons for validation and mapping of the DMR are indicated by the numbered rectangles. The bis-seq data (bottom panel) is visualized by the circles representing consecutive CpGs with black circles indicating methylated CpGs and white circles unmethylated CpGs, with each line being a unique DNA clone.CC BY · PubMed Central
Fig 2 Gain of DNA methylation in the promoter and gene body of JAZF1. A) Map showing multiple clusters of hyper-methylated CpGs in the promoter and gene body of JAZF1. The dashed and plain rectangles indicate clusters of CpGs with DM overlapping multiple individual enhancer regions. B) Validation and mapping of the DMR (d) in JAZF1 gene using bis-seq. The results from the Bis-seq for the amplicons indicated with number on the higher resolution gene map (top) are shown as QUMA blots (bottom). Every circle represents a single CpG. Black circles indicate methylated CpG and the white free of methylation CpG. The number of the amplicon and each individual sample ID are indicated on the top of every QUMA. The bis-seq data identify this DMR as a large 2.75 KB region spanning amplicons 5, 6 and 7.
Fig 2 Gain of DNA methylation in the promoter and gene body of JAZF1. A) Map showing multiple clusters of hyper-methylated CpGs in the promoter and gene body of JAZF1. The dashed and plain rectangles indicate clusters of CpGs with DM overlapping multiple individual enhancer regions. B) Validation and mapping of the DMR (d) in JAZF1 gene using bis-seq. The results from the Bis-seq for the amplicons indicated with number on the higher resolution gene map (top) are shown as QUMA blots (bottom). Every circle represents a single CpG. Black circles indicate methylated CpG and the white free of methylation CpG. The number of the amplicon and each individual sample ID are indicated on the top of every QUMA. The bis-seq data identify this DMR as a large 2.75 KB region spanning amplicons 5, 6 and 7.CC BY · PubMed Central
Fig 3 Analysis of 5mC and 5hmC in endometriosis lesions and stroma cells. A) Immunofluorescence analysis of the levels of expression of 5mC (green) and 5hmC (red) in tissue samples of women with endometriosis and controls, showing disease-dependent loss of 5hmC in the epithelial but not in the stromal cell compartment. Representative photos from a total number of n = 2 control and n = 2 endometriotic tissue are shown. B) The results of the standard and oxidative bis-seq for BDNF in endometriotic and control stromal cells represented as QUMA plots (left) and as bar graph (right). The QUMA plot and bar-graph show the percent methylation assessed by standard bis-seq (which scores indistinctly 5hmC and 5mC) and by modified bis-seq (which scores 5mC only) in control stroma and endometriotic stroma cells. The contribution of 5hmC in endometriotic and control stroma is inferred from the difference between the percent methylation at each CpG in the standard bis-seq reactions (5hmC + 5mC) and the percent methylation in the modified bis-seq reactions (5mC). C) The data of JAZF1 standard and oxidative bis-seq in endometriotic and control stromal cells represented as QUMA plots (left) and bar-graph (right) are shown.
Fig 3 Analysis of 5mC and 5hmC in endometriosis lesions and stroma cells. A) Immunofluorescence analysis of the levels of expression of 5mC (green) and 5hmC (red) in tissue samples of women with endometriosis and controls, showing disease-dependent loss of 5hmC in the epithelial but not in the stromal cell compartment. Representative photos from a total number of n = 2 control and n = 2 endometriotic tissue are shown. B) The results of the standard and oxidative bis-seq for BDNF in endometriotic and control stromal cells represented as QUMA plots (left) and as bar graph (right). The QUMA plot and bar-graph show the percent methylation assessed by standard bis-seq (which scores indistinctly 5hmC and 5mC) and by modified bis-seq (which scores 5mC only) in control stroma and endometriotic stroma cells. The contribution of 5hmC in endometriotic and control stroma is inferred from the difference between the percent methylation at each CpG in the standard bis-seq reactions (5hmC + 5mC) and the percent methylation in the modified bis-seq reactions (5mC). C) The data of JAZF1 standard and oxidative bis-seq in endometriotic and control stromal cells represented as QUMA plots (left) and bar-graph (right) are shown.CC BY · PubMed Central
Fig 4 DNA methylation changes at regulatory DNA elements in ROR1 and OSR2 correlate with gene expression. A) Map and XY graph of the DMRs in ROR1. Multiple hyper-methylated CpGs are identified in the gene body. Differences in fractional methylation between OESC and ESC are indicated for all CpGs with nominal p-value<0.05 in the bar graph. Chromatin state in NHLF and H1-ESC cell lines (ENCODE project) are color coded as described in the USCS browser. A positive correlation between methylation and expression is observed at cg19267457 (rectangle), overlapping an enhancer region (color coded in yellow). The XY graph shows expression levels, assessed by RNA-Seq and estimated by FPKM values, as a function of the fractional methylation assessed by Illumina BeadChip arrays at cg19267457. B) Map and XY graph of the DMRs in OSR2. Strong hyper-methylation is observed in and upstream OSR2. The DMRs overlapped a dynamic promoter, active in differentiated cells and poised in embryonic stem cells (color coded in red or purple, respectively). The cluster of DM CpGs in the gene (rectangle) shows a strong negative correlation between methylation and expression. The XY graph shows OSR2 expression level against the fractional methylation of the CpG with the highest absolute rho correlation coefficient.
Fig 4 DNA methylation changes at regulatory DNA elements in ROR1 and OSR2 correlate with gene expression. A) Map and XY graph of the DMRs in ROR1. Multiple hyper-methylated CpGs are identified in the gene body. Differences in fractional methylation between OESC and ESC are indicated for all CpGs with nominal p-value<0.05 in the bar graph. Chromatin state in NHLF and H1-ESC cell lines (ENCODE project) are color coded as described in the USCS browser. A positive correlation between methylation and expression is observed at cg19267457 (rectangle), overlapping an enhancer region (color coded in yellow). The XY graph shows expression levels, assessed by RNA-Seq and estimated by FPKM values, as a function of the fractional methylation assessed by Illumina BeadChip arrays at cg19267457. B) Map and XY graph of the DMRs in OSR2. Strong hyper-methylation is observed in and upstream OSR2. The DMRs overlapped a dynamic promoter, active in differentiated cells and poised in embryonic stem cells (color coded in red or purple, respectively). The cluster of DM CpGs in the gene (rectangle) shows a strong negative correlation between methylation and expression. The XY graph shows OSR2 expression level against the fractional methylation of the CpG with the highest absolute rho correlation coefficient.CC BY · PubMed Central
Fig 5 Validation of RNA-sequencing by Q-PCR and effects of 5Aza-dC on a subset of DM and DE genes in CESC and OESC. This figure shows average gene expression levels in CESC and OESC, from two or three biological replicates, after treatment with 5aza-dC for 72 hrs. All values were normalized to the mean of the non-treated CESC controls (0) set to 1. A) The relative expression of SLC22A23 under treatment with 5aza-dC increases in CESC as well as in OESC. In CESC, the increase in expression is dose dependent. B) The relative expression levels of OSR2 are decreased in CESC as well as in OESC under all tested doses of the demethylating agent. C) Treatment with 5aza-dC is associated with decreased relative expression levels of JAZF1 in both control and endometriotic stromal cells. D) Although in both CESC and OESC the ROR1 expression levels decrease under 5aza-dC treatment, in CESC the effect on gene expression is dose dependent and more pronounced compared to the endometriotic cells. E) While the HAND2 gene relative expression levels decrease after demethylation treatment as shown in the left bar graph, the HAND2as levels change in the opposite direction; the expression levels are increased in both CESC and OESC, especially at the highest level of 5aza-dC. DAPK1 (F) and TGFBR1 (G) expression levels are not influenced by the drug in CESC or in both CESC and OESCs, respectively. For direct comparison of Q-PCR and RNA-seq data, the differences in expression between CESC and OESC, identified by RNA-seq method are indicated below each graph. CESC, control endometrial stroma cells, OESC, ovarian ectopic endometriosis stroma cells. In each graph, † indicates conditions with biological duplicates.
Fig 5 Validation of RNA-sequencing by Q-PCR and effects of 5Aza-dC on a subset of DM and DE genes in CESC and OESC. This figure shows average gene expression levels in CESC and OESC, from two or three biological replicates, after treatment with 5aza-dC for 72 hrs. All values were normalized to the mean of the non-treated CESC controls (0) set to 1. A) The relative expression of SLC22A23 under treatment with 5aza-dC increases in CESC as well as in OESC. In CESC, the increase in expression is dose dependent. B) The relative expression levels of OSR2 are decreased in CESC as well as in OESC under all tested doses of the demethylating agent. C) Treatment with 5aza-dC is associated with decreased relative expression levels of JAZF1 in both control and endometriotic stromal cells. D) Although in both CESC and OESC the ROR1 expression levels decrease under 5aza-dC treatment, in CESC the effect on gene expression is dose dependent and more pronounced compared to the endometriotic cells. E) While the HAND2 gene relative expression levels decrease after demethylation treatment as shown in the left bar graph, the HAND2as levels change in the opposite direction; the expression levels are increased in both CESC and OESC, especially at the highest level of 5aza-dC. DAPK1 (F) and TGFBR1 (G) expression levels are not influenced by the drug in CESC or in both CESC and OESCs, respectively. For direct comparison of Q-PCR and RNA-seq data, the differences in expression between CESC and OESC, identified by RNA-seq method are indicated below each graph. CESC, control endometrial stroma cells, OESC, ovarian ectopic endometriosis stroma cells. In each graph, † indicates conditions with biological duplicates.CC BY · PubMed Central
Fig 6 WNT5A protein expression at the whole tissue level. Immunostaining for the WNT5A protein was done on FFPE sections of endometriotic (n = 14) and normal endometrial tissue (n = 14) samples. Representative pictures from control endometrium and endometriotic lesions at proliferative and secretory phase of the menstrual cycle are shown. The stromal = S and epithelial compartments = E are indicated. The results indicate down-regulation of the levels of WNT5A in the stroma of endometriosis vs. control endometrium, independent of the cycle phase.
Fig 6 WNT5A protein expression at the whole tissue level. Immunostaining for the WNT5A protein was done on FFPE sections of endometriotic (n = 14) and normal endometrial tissue (n = 14) samples. Representative pictures from control endometrium and endometriotic lesions at proliferative and secretory phase of the menstrual cycle are shown. The stromal = S and epithelial compartments = E are indicated. The results indicate down-regulation of the levels of WNT5A in the stroma of endometriosis vs. control endometrium, independent of the cycle phase.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 99 references

Cited by

See all 81

Metadata

Authors
Yotova, I., Hsu, E., Do, C., Gaba, A., Sczabolcs, M., Dekan, S., Kenner, L., Wenzl, R., & Tycko, B.
Affiliations
  • Columbia University Irving Medical Center (US)
  • Medical University of Vienna (AT)
  • University of Veterinary Medicine Vienna (AT)
Corresponding author
Yotova, Iveta
Venue
PLOS ONE
Published
2017-01-26
Volume
12
Issue
1
Pages
e0170859
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2581612752
Cited by
81
References
99
Citations by year
2026: 3 · 2025: 7 · 2024: 7 · 2023: 9 · 2022: 6 · 2021: 11 · 2020: 13 · 2019: 9 · 2018: 12 · 2017: 4
FWCI
12.04
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Columbia Academic Commons (Columbia University)
Funders
  • Schaefer Scholar Award at Columbia University of New York to Iveta Yotova and Benjamin Tycko
  • Institutional support to Iveta Yotova, Aulona Gaba and Rene Wenzl from Department of Obstetrics and Gynecology, Medical University of Vienna
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Plant and fungal interactions
Keywords
endometriosis, endometrial stromal cells, DNA methylation, CpG methylation, 5-hydroxymethylcytosine, transcription factors, JAZF1, brain-derived neurotrophic factor, DAPK1, ROR1, Wnt5a, HOXA, Hand2, Osr2, TBX3, steroidogenic factor 1, decitabine, differential gene expression, enhancers, epigenetic signatures, therapeutic target
MeSH terms
Wnt-5a Protein, Decitabine, Proto-Oncogene Mas, Adult, Azacitidine, Chromatin, DNA-Binding Proteins, Endometriosis, Endometrium, Female, Humans, Middle Aged, Neoplasm Proteins, Transcription Factors, Signal Transduction, Stromal Cells, Sequence Analysis, RNA, DNA Methylation, Brain-Derived Neurotrophic Factor, Organic Anion Transporters, Epigenesis, Genetic, Co-Repressor Proteins, Receptor Tyrosine Kinase-like Orphan Receptors, Molecular Sequence Annotation, Primary Cell Culture, Gene Ontology, Death-Associated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epigenetic Alterations Affecting Transcription Factors and Signaling Pathways in Stromal Cells of Endometriosis. https://app.cochat.ai/papers/10.1371/journal.pone.0170859
The paper
Yotova, I., Hsu, E., Do, C., Gaba, A., Sczabolcs, M., Dekan, S., Kenner, L., Wenzl, R., & Tycko, B. (2017). Epigenetic Alterations Affecting Transcription Factors and Signaling Pathways in Stromal Cells of Endometriosis. PLOS ONE. https://doi.org/10.1371/journal.pone.0170859

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.